Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ICAD

iCAD

$4.60

0.25 (5.75%)

08:25
03/28/19
03/28
08:25
03/28/19
08:25
Hot Stocks
iCAD names Stacey Stevens as president »

iCAD, Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ICAD

iCAD

$4.44

-0.02 (-0.45%)

16:10
03/18/19
03/18
16:10
03/18/19
16:10
Earnings
iCAD reports Q4 EPS (20c), two-estimate consensus (10c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ICAD

iCAD

$5.48

0.13 (2.43%)

17:41
02/27/19
02/27
17:41
02/27/19
17:41
Hot Stocks
iCAD enters exclusive relationship with researchers at Karolinska Institutet »

iCAD announced their…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAD

iCAD

$5.42

-0.16 (-2.87%)

17:02
01/31/19
01/31
17:02
01/31/19
17:02
Syndicate
Breaking Syndicate news story on iCAD »

iCAD files to sell 3.37M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
NVIV

InVivo Therapeutics

$1.56

-0.03 (-1.89%)

, ICAD

iCAD

$4.14

-0.01 (-0.24%)

08:08
01/14/19
01/14
08:08
01/14/19
08:08
Hot Stocks
InVivo Therapeutics appoitns Richard Christopher as CFO »

InVivo Therapeutics…

NVIV

InVivo Therapeutics

$1.56

-0.03 (-1.89%)

ICAD

iCAD

$4.14

-0.01 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAD

iCAD

$3.75

0.125 (3.45%)

08:18
01/07/19
01/07
08:18
01/07/19
08:18
Hot Stocks
iCAD: Study demonstrates effectiveness of Xoft system for BC treatment »

iCAD, Inc. announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

ICAD

iCAD

$3.51

-0.175 (-4.75%)

09:07
12/28/18
12/28
09:07
12/28/18
09:07
Recommendations
iCAD analyst commentary at Craig-Hallum »

iCAD 'in good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

ICAD

iCAD

$3.55

-0.135 (-3.66%)

16:05
12/27/18
12/27
16:05
12/27/18
16:05
Hot Stocks
iCAD CFO Richard Christopher to resign, Scott Areglado to be interim CFO »

iCAD announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

ICAD

iCAD

$3.73

-0.15 (-3.87%)

08:19
12/20/18
12/20
08:19
12/20/18
08:19
Syndicate
iCAD announces $7M private placement »

iCAD announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICAD

iCAD

$4.14

0.05 (1.22%)

08:05
12/07/18
12/07
08:05
12/07/18
08:05
Hot Stocks
iCAD receives FDA clearance for commercial sales, clinical use of ProFound AI »

iCAD announced clearance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.